Ivermectin Sensitivity and MDR1 Gene Testing for Border Collies

The Border Collie is widely recognised as one of the most intelligent and energetic working dog breeds. These dogs remain popular in the UK for herding livestock and excelling in canine sports due to their remarkable agility and trainability.

Beyond their working roles, Border Collie puppies make excellent pets for active families, provided they receive plenty of mental stimulation and physical exercise. Responsible ownership means dedicating time for walking and engaging activities to keep these lively dogs happy and healthy.

While generally hardy and robust, Border Collies can inherit certain genetic conditions over time that affect their health and require careful management.

One important hereditary concern is Ivermectin sensitivity, caused by a mutation in the MDR1 gene (also known as ABCB1). This condition renders affected dogs highly sensitive to certain common veterinary medications, including some wormers and treatments for allergies and other health issues.

Dogs with this gene defect cannot properly process these medications, leading to potentially severe neurological toxicity, symptoms such as seizures, paralysis, and in serious cases, death.

Since you cannot visually detect if a Border Collie carries this sensitivity, DNA testing is invaluable. It identifies if a dog is clear, a carrier, or affected by the MDR1 gene mutation, allowing owners and vets to avoid harmful drugs and select safer treatment options.

For breeders, DNA testing supports responsible breeding by enabling them to avoid mating two carriers or affected dogs, thereby reducing the incidence of Ivermectin sensitivity in future litters. This proactive approach improves the overall health and longevity of the breed.

What is Ivermectin sensitivity or MDR1 gene defect?

Ivermectin is a widely used antiparasitic medication effective against worms and other pests. However, dogs with the MDR1 gene defect are sensitive not only to Ivermectin but also to many related medicines containing macrocyclic lactones.

This defect affects the P-glycoprotein, a protein that normally pumps these drugs out of the brain. When defective, the drugs accumulate in the central nervous system, causing dangerous neurological reactions.

Symptoms of sensitivity include tremors, seizures, disorientation, excessive drooling, and in severe cases, coma. Prompt diagnosis is essential to prevent fatal outcomes.

Fortunately, alternative medications exist for most conditions requiring Ivermectin-like drugs, enabling safe treatment when the genetic status is known.

How is Ivermectin sensitivity or MDR1 gene defect inherited?

The MDR1 mutation follows an autosomal recessive inheritance pattern. Dogs can be:

• Clear (no mutation, safe from sensitivity)
• Carriers (one copy of mutation, usually unaffected but can pass the gene on)
• Affected (two copies of mutation, demonstrating sensitivity)

Understanding the genetic status of both parent dogs is crucial in predicting puppies’ vulnerability:

• Two affected parents produce litters where all puppies inherit sensitivity.
• Two clear parents produce litters free from the mutation.
• Two carrier parents have puppies with a 25% chance affected, 50% carriers, and 25% clear.
• A combination of affected, carrier, and clear parents leads to predictable mixes of these statuses.

DNA testing for Ivermectin sensitivity in Border Collies

To check your Border Collie's MDR1 status, your vet can take a simple blood sample or cheek swab. The sample is sent to an accredited laboratory which tests for the 4-base pair deletion mutation responsible.

Once tested, results categorise your dog as clear, carrier, or affected. This information guides both veterinary treatment decisions to avoid harmful drugs and breeding decisions.

Testing is considered best practice for herding breeds like the Border Collie, Australian Shepherd, and Shetland Sheepdog, where the gene mutation is more common – up to 75% of individuals may carry the mutation.

Responsible breeding and care

Using DNA testing to inform mating choices helps reduce the prevalence of the MDR1 mutation in the breed. Avoiding the pairing of two carriers or affected dogs limits the risk of producing sensitive puppies.

Additionally, owners of dogs identified as sensitive should inform their vets and avoid administering ivermectin or similar drugs, opting for safer alternatives.

This knowledge protects the health and well-being of Border Collies, helping them enjoy long, active lives in both working and pet roles.

FAQs about MDR1 gene defect and Border Collies

Can I tell if my Border Collie has Ivermectin sensitivity without a test?

Quick Answer: No, appearance does not reveal sensitivity; DNA testing is required.

Although symptoms appear after exposure to certain medications, the MDR1 gene defect cannot be detected visually. Genetic testing is the only reliable method to determine if a dog carries or is affected by the mutation.

Is the MDR1 mutation only found in Border Collies?

Quick Answer: No, it also occurs in related herding breeds including Australian Shepherds and Shetland Sheepdogs.

The mutation is common in several collie-related breeds due to shared ancestry. Testing is recommended wherever these breeds are present to avoid adverse drug reactions.

What happens if a dog with the MDR1 mutation takes Ivermectin?

Quick Answer: The dog may suffer severe neurological effects including seizures and possibly death.

Because the defective P-glycoprotein fails to protect the brain from the drug, Ivermectin can accumulate to toxic levels leading to symptoms like tremors, loss of coordination, and seizures, which require immediate veterinary intervention.

Early identification through DNA testing helps prevent exposure and keeps affected dogs safe.

Where can I get my Border Collie tested?

Quick Answer: Many UK veterinary practices offer MDR1 DNA testing using blood or cheek swabs.

Speak to your vet about requesting this test. It is widely available and recommended as a precaution before using relevant medications or breeding.

Results typically return within a few weeks and guide safer healthcare decisions for your dog.

Conclusion

Understanding Ivermectin sensitivity and the MDR1 gene defect is vital for the health and safety of Border Collies. DNA testing empowers owners and breeders to prevent toxic drug reactions and make informed choices with veterinary guidance.

By promoting responsible breeding and alert care, we can ensure these remarkable dogs continue to thrive happily in homes and working environments across the UK.